Curasen Therapeutics, Inc.
Records under this name other than the patents Curasen Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Back to Curasen Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| 16/972,985 | Methods for Diagnosing, Monitoring and Treating Neurological Diseases and Disorders Abandoned Abandoned Sep 28, 2024 | Abandoned | Abandoned Sep 28, 2024 | |
| 17/100,758 | METHODS FOR TREATING NEUROLOGICAL DISORDERS WITH a1A-AR PARTIAL AGONISTS Abandoned Abandoned Jun 20, 2023 | Abandoned | Abandoned Jun 20, 2023 | |
| 17/251,142 | Methods for Improving Neurological Diseases and Disorders Abandoned Abandoned Jul 1, 2024 | Abandoned | Abandoned Jul 1, 2024 | |
| 17/355,063 | Beta Adrenergic Agonist and Methods of Using the Same Abandoned Abandoned Aug 8, 2023 | Abandoned | Abandoned Aug 8, 2023 | |
| 17/770,276 | Methods for Treating Neurological Disorders with ALPHA1A-AR Partial Agonists Abandoned Abandoned Feb 21, 2026 | Abandoned | Abandoned Feb 21, 2026 | |
| 18/007,726 | Forms and Compositions of a Beta Adrenergic Agonist Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/023,693 | Compositions and Methods for Improving Neurological Diseases and Disorders Abandoned Abandoned Apr 2, 2026 | Abandoned | Abandoned Apr 2, 2026 | |
| 18/035,262 | Beta Adrenergic Agonist and Methods of Using the Same Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/198,191 | Compositions and Methods for Treating Patients with Amyotrophic Lateral Sclerosis (ALS) Abandoned Abandoned Apr 21, 2025 | Abandoned | Abandoned Apr 21, 2025 | |
| 18/694,362 | Beta Adrenergic Agonist and Methods of Using the Same Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |